NM_000055.4:c.1240C>T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000055.4(BCHE):c.1240C>T(p.Arg414Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000055.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCHE | NM_000055.4 | c.1240C>T | p.Arg414Cys | missense_variant | Exon 2 of 4 | ENST00000264381.8 | NP_000046.1 | |
BCHE | NR_137636.2 | n.1358C>T | non_coding_transcript_exon_variant | Exon 2 of 5 | ||||
BCHE | NR_137635.2 | n.110+7520C>T | intron_variant | Intron 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151922Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250530Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135390
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461642Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727110
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151922Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74196
ClinVar
Submissions by phenotype
Deficiency of butyrylcholinesterase Pathogenic:3
Variant summary: BCHE c.1240C>T (p.Arg414Cys) results in a non-conservative amino acid change located in the Carboxylesterase, type B (IPR002018) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-05 in 250530 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in BCHE causing Deficiency Of Butyrylcholine Esterase (4e-05 vs 0.016), allowing no conclusion about variant significance. c.1240C>T has been reported in the literature in individuals affected with Deficiency Of Butyrylcholine Esterase (Whittington_2012, Yen_2003, On-Kei_2005). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function demonstrates reduced enzyme activity in a homozygous patient (Whittington_2012) and in recombinant cells (Brazzolotto_2021). The following publications have been ascertained in the context of this evaluation (PMID: 33024248, 15563885, 22378569, 12881446). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
PM2_Supporting+PP3_Strong+PM3_Strong+PP4 -
- -
BCHE-related disorder Pathogenic:1
The BCHE c.1240C>T variant is predicted to result in the amino acid substitution p.Arg414Cys. This variant (referred to as p.Arg386Cys in the literature) was previously reported, also in the homozygous state, in a patient who presented with post-succinylcholine paralysis and severely reduced butyrylcholinesterase enzyme activity (Whittington et al. 2012. PubMed ID: 22378569). In vitro analysis of recombinant variant protein suggested that the p.Arg414Cys change results in retention of the variant protein in the endoplasmic reticulum (Brazzolotto et al. 2020. PubMed ID: 33024248). Additionally, this variant was also identified in the heterozygous state in an individual who presented with prolonged post-succinylcholine apnea (Yen et al. 2003. PubMed ID: 12881446). At PreventionGenetics, we previously identified this variant in the apparently homozygous state in an individual with suspected BCHE deficiency after an adverse reaction post-surgery (internal data). Taken together, we classify the c.1240C>T variant as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at